{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:07:20Z","timestamp":1787062040201,"version":"build-2736575974"},"reference-count":58,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1673,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1365-2133.2010.10110.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T12:51:39Z","timestamp":1288356699000},"page":"no-no","source":"Crossref","is-referenced-by-count":48,"title":["A systematic review of drug-induced subacute cutaneous lupus erythematosus"],"prefix":"10.1093","author":[{"given":"G.","family":"Lowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Sontheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB1|cit1","first-page":"7","volume-title":"Dubois\u2019 Lupus Erythematosus","author":"Rubin","year":"2007"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2004.10.003","article-title":"Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings","volume":"4","author":"Sontheimer","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/15563659509010639","article-title":"Thiazide diuretics induce cutaneous lupus-like adverse reaction","volume":"33","author":"Brown","year":"1995","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0190-9622(88)70005-5","article-title":"Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene","volume":"18","author":"Darken","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0046-8177(97)90281-1","article-title":"Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy","volume":"28","author":"Crowson","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB8|cit8","first-page":"506","article-title":"Case report: verapamil-induced subacute cutaneous lupus erythematosus","volume":"4","author":"Kurtis","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0961203307087189","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions","volume":"17","author":"Marzano","year":"2008","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1610-0387.2008.06806.x","article-title":"Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature","volume":"6","author":"Lorentz","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1111\/j.1365-2230.2009.03380.x","article-title":"Subacute cutaneous lupus erythematosus associated with terbinafine","volume":"34","author":"Kasperkiewicz","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0190-9622(89)80031-3","article-title":"Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin","volume":"21","author":"Miyagawa","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1365-2133.1998.2576q.x","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"139","author":"Brooke","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-4632.2004.02472.x","article-title":"Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil","volume":"45","author":"Cetkovska","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000089024","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"212","author":"Farhi","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.2004.01527.x","article-title":"Subacute cutaneous lupus erythematosus associated with leflunomide","volume":"29","author":"Kerr","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2007.08367.x","article-title":"Anastrozole-induced subacute cutaneous lupus erythematosus","volume":"158","author":"Trancart","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.2008.08587.x","article-title":"Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma","volume":"159","author":"Wiechert","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/anr.1780320318","article-title":"Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature","volume":"32","author":"Dowdy","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0190-9622(08)80652-4","article-title":"Hydrochlorothiazide-induced lupus erythematosus: a new variant?","volume":"28","author":"Goodrich","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1191\/0961203304lu2020oa","article-title":"Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus","volume":"13","author":"Albrecht","year":"2004","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1346-8138.2007.00313.x","article-title":"Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA\/Ro antibody","volume":"34","author":"Adachi","year":"2007","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2003.019323","article-title":"Lupus erythematosus with leflunomide: induction or reactivation?","volume":"64","author":"Gensburger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000247739","article-title":"Systemic lupus erythematosus exacerbated by piroxicam","volume":"182","author":"Roura","year":"1991","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB27|cit27","volume-title":"The Skin in Systemic Autoimmune Diseases","author":"Sontheimer","year":"2006"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archderm.138.9.1175","article-title":"Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus","volume":"138","author":"Black","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB29|cit29","first-page":"46","article-title":"[Lyell syndrome and Stevens-Johnson syndrome caused by lamotrigine]","volume":"126","author":"Bocquet","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10227-002-0122-5","article-title":"Subacute cutaneous lupus erythematosus induced by nifedipine","volume":"7","author":"Gubinelli","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB31|cit31","first-page":"213","article-title":"Nitrendipine-induced subacute cutaneous lupus erythematosus","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2230.1979.tb01595.x","article-title":"A distinctive eruption in patients receiving oxprenolol","volume":"4","author":"Gange","year":"1979","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000086668","article-title":"Acebutolol-induced subacute cutaneous lupus erythematosus","volume":"18","author":"Fenniche","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(95)90392-5","article-title":"Subacute cutaneous lupus erythematosus associated with cilazapril","volume":"345","author":"Fernandez-Diaz","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/00015550410018361","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"84","author":"McKay","year":"2004","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Bonsmann","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.137.9.1196","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases","volume":"137","author":"Callen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB38|cit38","first-page":"818","article-title":"Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000083798","article-title":"Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases","volume":"210","author":"Fumal","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archdermatol.2008.619","article-title":"Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy","volume":"145","author":"Fernandes","year":"2009","journal-title":"Arch Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2010.10110.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2007.06.040","article-title":"Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine","volume":"59","author":"Weger","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0560.1999.tb01809.x","article-title":"Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy","volume":"26","author":"Crowson","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1191\/096120398678920244","article-title":"Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy","volume":"7","author":"Toll","year":"1998","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/keh586","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Goeb","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(05)79887-1","article-title":"Subacute cutaneous lupus erythematosus associated with interferon beta-1a","volume":"352","author":"Nousari","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archderm.141.1.103","article-title":"Ro\/SSA-positive cutaneous lupus erythematosus induced by carbamazepine","volume":"141","author":"Capponi","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB47|cit47","first-page":"281","article-title":"Drug-induced cutaneous lupus erythematosus after 5\u2003years of treatment with carbamazepine","volume":"16","author":"Amerio","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1365-2230.2002.01107.x","article-title":"Subacute cutaneous lupus erythematosus associated with phenytoin","volume":"27","author":"Ross","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000077320","article-title":"Lupus-like syndrome associated with statin therapy","volume":"208","author":"Noel","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/40.11.1317","article-title":"Etanercept-induced subacute cutaneous lupus erythematosus","volume":"40","author":"Bleumink","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2010.10110.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.jaad.2005.10.037","article-title":"Efalizumab-induced subacute cutaneous lupus erythematosus","volume":"54","author":"Bentley","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB52|cit52","first-page":"353","article-title":"Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases","volume":"85","author":"Bracke","year":"2005","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.268.1.51","article-title":"Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus","volume":"268","author":"Parodi","year":"1992","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.1780330229","article-title":"Subacute cutaneous lupus erythematosus during psoralen ultraviolet A therapy","volume":"33","author":"McGrath","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-0960.2005.00199.x","article-title":"Bupropion-induced subacute cutaneous lupus erythematosus","volume":"46","author":"Cassis","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/archderm.141.7.911","article-title":"Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium","volume":"141","author":"Pham","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-4632.2006.02783.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine","volume":"45","author":"Reich","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10110.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-4632.2004.02013.x","article-title":"Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual","volume":"43","author":"Shapiro","year":"2004","journal-title":"Int J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10110.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10110.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T18:11:13Z","timestamp":1711908673000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/3\/465\/6643972"}},"subtitle":["Systematic review of drug-induced SCLE"],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":58,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10110.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}